Results 141 to 150 of about 5,939 (158)

Upadacitinib

Reactions Weekly, 2023
  +10 more sources

Management of Axial Spondyloarthritis – Insights into Upadacitinib

Drug Design, Development and Therapy, 2022
Uta Kiltz, Xenofon Baraliakos
exaly  

Upadacitinib

Reactions Weekly, 2022
openaire   +1 more source

Upadacitinib for Patients with Rheumatoid Arthritis: A Comprehensive Review

Journal of Clinical Medicine, 2023
Hector Corominas, Raimon Sanmartí, Corominas Hector   +2 more
exaly  

Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials

Lancet, The, 2021
Amy Paller, Diamant Thaçi, H Chih-Ho Hong   +2 more
exaly  

Multicentre Real-world Experience of Upadacitinib in the Treatment of Crohn’s Disease

Journal of Crohn's and Colitis, 2023
Edward Loftus, , Thomas Fredrick
exaly  

Evaluating Upadacitinib in the Treatment of Moderate-to-Severe Active Ulcerative Colitis: Design, Development, and Potential Position in Therapy

Drug Design, Development and Therapy, 2022
Silvio Danese, Ferdinando D'Amico, Laurent Peyrin-Biroulet   +2 more
exaly  

The efficacy and immunological effects of upadacitinib in the treatment of moderate-to-severe Chinese atopic dermatitis patients

International Immunopharmacology, 2023
Chen Shen, Lu Li
exaly  

Characterization of the Effect of Renal Impairment on Upadacitinib Pharmacokinetics

Journal of Clinical Pharmacology, 2019
Jaclyn Anderson, Ahmed A Othman, Tian Feng   +2 more
exaly  

Assessment of effect of CYP3A inhibition, CYP induction, OATP1B inhibition, and high‐fat meal on pharmacokinetics of the JAK1 inhibitor upadacitinib

British Journal of Clinical Pharmacology, 2017
Ahmed A Othman
exaly